EFFECT OF 52 WEEKS OF MIRIKIZUMAB ON INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE SCORES IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE
Laurent Peyrin-Biroulet 1
Bruce E. Sands 2
William Sandborn 3
Peter D.R. Higgins 4
Fumihito Hirai 5
Vipul Jairath 6
Ruth Belin
Yan Dong
Elisa Gomez Valderas
Debra Miller
Vipin Arora
April Naegeli
Paul Pollack
Jay Tuttle
Toshifumi Hibi
1 Nancy University Hospital Inserm U954,Vandoeuvre les Nancy,France
2 Icahn School of Medicine at Mount Sinai,New York,United States
3 University of California San Diego,La Jolla,United States
4 University of Michigan Health System School of Public Health,Ann Arbor,United States
5 Fukuoka University Chikushi Hospital,Chikushino,Japan
6 Unive
Session
IBD (Posters)
Conference
UEG Week Virtual 2020
Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]